UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
___________
FORM 8-K
CURRENT REPORT
Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934
| |
|
|
Date of Report (Date of earliest event reported)
|
|
September 8, 2005 |
|
|
|
Targeted Genetics Corporation
(Exact name of registrant as specified in its charter)
| |
|
|
|
|
| Washington
|
|
0-23930
|
|
91-1549568 |
|
|
|
|
|
|
(State or other jurisdiction
of incorporation)
|
|
(Commission File
Number)
|
|
(IRS Employer
Identification No.) |
| |
|
|
| 1100 Olive Way, Suite 100, Seattle, Washington
|
|
98101 |
|
|
|
|
| (Address of principal executive offices)
|
|
(Zip Code) |
| |
|
|
Registrant’s telephone number, including area code
|
|
(206) 623-7612 |
|
|
|
Not Applicable
(Former name or former address if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
TABLE OF CONTENTS
Item 5.02. Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.
On
September 8, 2005, Mr. Mark H. Richmond, age 74, notified Targeted
Genetics of his decision to retire from his position as a board
member effective October 31, 2005. Mr. Richmond’s retirement from the
Targeted Genetics board, follows his retirement from other boards on
which he served.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
|
|
|
|
| |
Targeted Genetics Corporation
|
|
| |
By: |
/s/ Todd E. Simpson
|
|
| |
|
Todd E. Simpson |
|
| |
|
Vice President, Finance and Administration and Chief Financial
Officer, Secretary and Treasurer
(Principal Financial and Accounting Officer) |
|
| |
Dated: September 13, 2005
3